If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 11 - 20 of 299
A Phase 1/2, First-in-Human Study of the Menin-KMT2A (MLL1) Inhibitor Bleximenib in Participants with Acute Leukemia
Objective
This project is being done to see if a safe dose of JNJ-75276617 can be identified for treating participants with acute leukemia, including acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL).
Protocol No
JNJ-75276617ALE1001
A Phase III, Open-Label, Randomised Study of Osimertinib With or Without Datopotamab Deruxtecan (Dato-DXd), as First-Line Treatment in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation-Positive, Locally Advanced or Metastatic Non-Sma
Objective
Study of first-line osimertinib with or without Dato-Dxd for EGFRm locally advanced or metastatic NS
Protocol No
AZ-D516NC00001-TROPION-LUNG14
Categories
Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain (VANISH)
Objective
Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain
Protocol No
SURG-ATRICURE-VANISH
Categories
Platform Clinical Study for Conquering Scleroderma: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2b Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants With Interstitial Lung D
Objective
Platform Clinical Study for Conquering Scleroderma
Protocol No
RHEU-SRF-CONQUEST
Categories
A Multi-Phase, Pharmacokinetics, Safety, and Efficacy Study of ASTX030 (Azacitidine and Cedazuridine) as Monotherapy in Subjects with Myeloid Neoplasm or in Combination with Venetoclax in Subjects with AML (AZTOUND Study)
Objective
Study of ASTX030 versus subcutaneous azacitidine for MDS, CMML or AML patients
Protocol No
TAIHO-ASTX030-01
Categories
A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)
Objective
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Protocol No
NRG-GI011
Categories
A Phase II Randomized Trial of Adjuvant Therapy with Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma with High Risk Features
Objective
Adjuvant Therapy with Pembrolizumab after Resection of Recurrent/Second Primary HNSCC
Protocol No
ECOG-EA3191
Categories
Self-Sampling to Optimize Anal Lesion Outcomes (SOLO) Protocol
Objective
Self-sampling to Optimize Anal Lesion Outcomes
Protocol No
IIT-NYITRAY-SOLO
Categories
A Phase 1b/2 Open-Label Clinical Study to Evaluate the Safety and Efficacy of MK-6070 and Ifinatamab Deruxtecan (I-DXd) in Participants with Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer
Objective
A Phase 1b 2 Study of MK-6070 and I-DXd in Patients with RR Extensive Stage SCLC
Protocol No
MERCK-MK-6070-002
Categories
A Phase 1a/1b Study of the Safety, Pharmacokinetics, and Antitumor Activity of the Oral Menin Inhibitor Ziftomenib in Combination with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors (GIST) After Imatinib Failure
Objective
A Phase 1a 1b Study of Oral Ziftomenib in Patients with Advanced GIST after Imatinib Failure
Protocol No
KURA-KO-MEN-015
Categories